公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 REVVITY DO BRASIL LTDA取消

92 记录

产品持有公司班级有效性
Lifecycle 7.0 PN 5015 700010298919007REVVITY DO BRASIL LTDAII现有
MSMS Workstation PN 5002-054010298919008REVVITY DO BRASIL LTDAII现有
FAMÍLIA DE KITS DELFIA/AUTODELFIA T4 NEONATAL TIROXINA10298910003REVVITY DO BRASIL LTDAIII23/09/2036
FAMÍLIA DE KITS DELFIA/AUTODELFIA TSH NEONATAL TIROTROPINA10298910010REVVITY DO BRASIL LTDAIII23/09/2036
KIT DELFIA AUTODELFIA 17 ALFA-HIDROXIPROGESTERONA NEONATAL10298910015REVVITY DO BRASIL LTDAIII23/09/2036
FAMÍLIA DE KITS DELFIA/AUTODELFIA IRT NEONATAL TRIPSINA IMUNOREATIVA10298910032REVVITY DO BRASIL LTDAIII23/09/2036
NEONATAL PHENYLALANINE KIT10298910054REVVITY DO BRASIL LTDAIII21/07/2034
DELFIA XPRESS FREE hCGß10298910071REVVITY DO BRASIL LTDAIII25/11/2034
DELFIA XPRESS PAPP-A10298910072REVVITY DO BRASIL LTDAIII25/11/2034
G6PD NEONATAL10298910073REVVITY DO BRASIL LTDAIII07/03/2035
DELFIA XPRESS hAFP10298910086REVVITY DO BRASIL LTDAIII08/10/2027
NEONATAL TOTAL GALACTOSE KIT10298910089REVVITY DO BRASIL LTDAIII14/04/2028
NEO NATAL BIOTINIDASE KIT10298910092REVVITY DO BRASIL LTDAIII14/07/2033
NeoBase Non-Derivatized MSMS Kit10298910097REVVITY DO BRASIL LTDAIII13/04/2034
NEONATAL GALT KIT10298910099REVVITY DO BRASIL LTDAIII16/07/2034
GSP NEONATAL hTSH Kit10298910100REVVITY DO BRASIL LTDAIII10/05/2035
GSP Neonatal Thyroxine (T4)10298910102REVVITY DO BRASIL LTDAIII17/05/2035
GSP Neonatal 17 a-OH-progesterone kit10298910105REVVITY DO BRASIL LTDAIII23/06/2035
GSP Neonatal GALT kit10298910106REVVITY DO BRASIL LTDAIII23/06/2035
GSP Neonatal IRT Kit10298910112REVVITY DO BRASIL LTDAIII20/08/2037
DELFIA/AutoDELFIA PlGF Kit10298910118REVVITY DO BRASIL LTDAIII15/10/2027
GSP Neonatal Phenylalanine Kit10298910119REVVITY DO BRASIL LTDAIII17/12/2027
GSP NEONATAL BIOTINIDASE KIT10298910122REVVITY DO BRASIL LTDAIII31/03/2034
GSP NEONATAL G6PD KIT10298910130REVVITY DO BRASIL LTDAIII08/06/2035
Delfia Xpress PlGF 1-2-3 Kit10298910137REVVITY DO BRASIL LTDAIII04/07/2036

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家